Generation of induced neural stem cells with inducible IDH1R132H for analysis of glioma development and drug testing
Mutation in isocitrate dehydrogenase 1 (IDH1R132H) occurs in various types of cancer, including low and high grade gliomas. Despite high incidence indicating its central role in tumor initiation and progression there are no targeted therapies directed against this oncogene available in the clinic. T...
Main Authors: | Kamila Rosiak-Stec, Dagmara Grot, Piotr Rieske, Ilya Ulasov |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7500637/?tool=EBI |
Similar Items
-
Generation of induced neural stem cells with inducible IDH1R132H for analysis of glioma development and drug testing.
by: Kamila Rosiak-Stec, et al.
Published: (2020-01-01) -
IDH1R132H in Neural Stem Cells: Differentiation Impaired by Increased Apoptosis.
by: Kamila Rosiak, et al.
Published: (2016-01-01) -
Expression of CD44 and IDH1 R132H in Gliomas and their Prognostic Relevance
by: Jakovļevs Arvīds, et al.
Published: (2020-10-01) -
IDH1R132H Mutation Increases U87 Glioma Cell Sensitivity to Radiation Therapy in Hypoxia
by: Xiao-Wei Wang, et al.
Published: (2014-01-01) -
The neural stem-cell marker CD24 is specifically upregulated in IDH-mutant glioma
by: Patricia D.B. Tiburcio, et al.
Published: (2020-10-01)